Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and...
-
Upload
moses-marshall -
Category
Documents
-
view
217 -
download
4
Transcript of Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and...
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
Ross L. Levine, Martha Wadleigh, Jan Cools, Benjamin L. Ebert, Gerlinde Wernig, Brian J.P. Huntly, Titus J. Boggon, Iwona Wlodarska, Jennifer J. Clark, Sandra Moore, Jennifer Adelsperger, Sumin Koo, Jeffrey C. Lee, Stacey Gabriel, Thomas Mercher, Alan D’Andrea,
Stefan Fröhling, Konstanze Döhner, Peter Marynen, Peter Vandenberghe, Ruben A. Mesa, Ayalew Tefferi, James D. Griffin, Michael J. Eck, William R. Sellers, Matthew Meyerson, Todd R. Golub, Stephanie J. Lee, D. Gary Gilliland
Cancer Cell Volume 7, Issue 4, Pages 387-397 (April 2005)
DOI: 10.1016/j.ccr.2005.03.023
Copyright © 2005 Elsevier Inc. Terms and Conditions
Figure 1
Cancer Cell 2005 7, 387-397DOI: (10.1016/j.ccr.2005.03.023) Copyright © 2005 Elsevier Inc. Terms and Conditions
Figure 2
Cancer Cell 2005 7, 387-397DOI: (10.1016/j.ccr.2005.03.023) Copyright © 2005 Elsevier Inc. Terms and Conditions
Figure 3
Cancer Cell 2005 7, 387-397DOI: (10.1016/j.ccr.2005.03.023) Copyright © 2005 Elsevier Inc. Terms and Conditions
Figure 4
Cancer Cell 2005 7, 387-397DOI: (10.1016/j.ccr.2005.03.023) Copyright © 2005 Elsevier Inc. Terms and Conditions